Download PDF
1 / Pages

Other users also viewed these articles

Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina Federico Guillermo Villamil; Manuel Barbero; Nancy Elena Massenzio; Sandra Mónica Giani; Shigeru Kozima; Fernando Mario Cairo; Rodrigo Agustín Belloni; Javier Mariani; Mercedes Rodriguez Gazari; Paola Evangelina Coisson; Sonia Carolina Gallardo; Paula Andrea Cocco; Claudia Mabel Riboldi; Patricia Eugenia Gallardo;
Ann Hepatol. 2023;28:
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents Diego García-Compeán; Ramesh Kumar; Ángel Noe del Cueto-Aguilera; Héctor Jesús Maldonado-Garza; Jesús Zacarías Villarreal-Pérez;
Ann Hepatol. 2023;28:
Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease Facundo Maiorana; Magali Neschuk; María Virginia Caronia; Karina Elizondo; Adolfo Schneider; Georgina Veron; Pedro D Zapata; Fernando Javier Barreyro;
10.1016/j.aohep.2024.101541